O43933 (PEX1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 117.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Peroxisome biogenesis factor 1 Alternative name(s): Peroxin-1 Peroxisome biogenesis disorder protein 1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1283 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Required for stability of PEX5 and protein import into the peroxisome matrix. Anchored by PEX26 to peroxisome membranes, possibly to form heteromeric AAA ATPase complexes required for the import of proteins into peroxisomes. |
| Subunit structure | Interacts directly with PEX6. Interacts indirectly with PEX26, via its interaction with PEX6. Ref.10 |
| Subcellular location | Cytoplasm. Peroxisome membrane. Note: Associated with peroxisomal membranes. |
| Involvement in disease | Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:214100]: A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). Peroxisome biogenesis disorder 1A (PBD1A) [MIM:214100]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum. PBD1A is an autosomal recessive systemic disorder characterized clinically by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. Peroxisome biogenesis disorder 1B (PBD1B) [MIM:601539]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. |
| Sequence similarities | Belongs to the AAA ATPase family. |
| Sequence caution | The sequence AAB46346.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PEX6 | Q13608 | 2 | EBI-988601,EBI-988581 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1283 | 1283 | Peroxisome biogenesis factor 1 | PRO_0000084604 | |||||
Regions | |||||||||
| Nucleotide binding | 599 – 606 | 8 | ATP Potential | ||||||
| Nucleotide binding | 881 – 888 | 8 | ATP Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 1209 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 1211 | 1 | Phosphoserine By similarity | ||||||
| Cross-link | 833 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.11 | |||||||
Natural variations | |||||||||
| Natural variant | 590 | 1 | L → R in PBD-CG1. Ref.17 | VAR_058376 | |||||
| Natural variant | 593 | 1 | G → R in PBD-CG1. Ref.17 | VAR_058377 | |||||
| Natural variant | 634 – 690 | 57 | Missing in PBD1A and PBD1B. | VAR_014358 | |||||
| Natural variant | 640 | 1 | I → R. Corresponds to variant rs4559173 [ dbSNP | Ensembl ]. | VAR_048113 | |||||
| Natural variant | 664 | 1 | L → P in PBD1A and PBD1B. Ref.3 Corresponds to variant rs28939678 [ dbSNP | Ensembl ]. | VAR_008876 | |||||
| Natural variant | 696 | 1 | I → M. Ref.5 Ref.17 Corresponds to variant rs35996821 [ dbSNP | Ensembl ]. | VAR_034376 | |||||
| Natural variant | 798 | 1 | R → G in PBD-CG1. Ref.17 | VAR_058378 | |||||
| Natural variant | 843 | 1 | G → D in PBD1A and PBD1B. Ref.1 Ref.2 Ref.3 Ref.4 | VAR_008877 | |||||
| Natural variant | 948 | 1 | R → Q. Ref.17 | VAR_058379 | |||||
| Natural variant | 1237 | 1 | A → E in PBD-CG1. Ref.17 | VAR_058380 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders." Portsteffen H., Beyer A., Becker E., Epplen C., Pawlak A., Kunau W.-H., Dodt G. Nat. Genet. 17:449-452(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT PBD1A/PBD1B ASP-843. |
| [2] | "Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders." Reuber B.E., Germain-Lee E., Collins C.S., Morrell J.C., Ameritunga R., Moser H.W., Valle D., Gould S.J. Nat. Genet. 17:445-448(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANT PBD1A ASP-843, VARIANT PBD1B ASP-843. |
| [3] | "Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I." Tamura S., Okumoto K., Toyama R., Shimozawa N., Tsukamoto T., Suzuki Y., Osumi T., Kondo N., Fujiki Y. Proc. Natl. Acad. Sci. U.S.A. 95:4350-4355(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS PBD1A 634-GLY--HIS-690 DEL; PRO-664 AND ASP-843, VARIANTS PBD1B 634-GLY--HIS-690 DEL; PRO-664 AND ASP-843. |
| [4] | "Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction." Tamura S., Matsumoto N., Imamura A., Shimozawa N., Suzuki Y., Kondo N., Fujiki Y. Biochem. J. 357:417-426(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT PBD1B ASP-843. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT MET-696. Tissue: Trachea. |
| [6] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lymph. |
| [10] | "The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes." Matsumoto N., Tamura S., Fujiki Y. Nat. Cell Biol. 5:454-460(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PEX26 AND PEX6. |
| [11] | "Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry." Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D. Proteomics 7:868-874(2007) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-833, MASS SPECTROMETRY. Tissue: Mammary cancer. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [13] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [14] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1209, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [16] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders." Yik W.Y., Steinberg S.J., Moser A.B., Moser H.W., Hacia J.G. Hum. Mutat. 30:E467-E480(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PBD-CG1 ARG-590; ARG-593; GLY-798 AND GLU-1237, VARIANTS MET-696 AND GLN-948. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF030356 mRNA. Translation: AAB99758.1. AF026086 mRNA. Translation: AAB87880.1. AB008112 mRNA. Translation: BAA85162.1. AB052090 mRNA. Translation: BAB59061.1. AB052091 mRNA. Translation: BAB59062.1. AB052092 mRNA. Translation: BAB59063.1. AK292955 mRNA. Translation: BAF85644.1. AC007566 Genomic DNA. No translation available. AC000064 Genomic DNA. Translation: AAB46346.1. Sequence problems. CH236949 Genomic DNA. Translation: EAL24149.1. CH471091 Genomic DNA. Translation: EAW76840.1. BC035575 mRNA. Translation: AAH35575.1. |
| IPI | IPI00411291. |
| RefSeq | NP_000457.1. NM_000466.2. |
| UniGene | Hs.164682. |
3D structure databases | |
| ProteinModelPortal | O43933. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O43933. 3 interactions. |
| STRING | 9606.ENSP00000248633. |
Protein family/group databases | |
| TCDB | 3.A.20.1.1. peroxisomal protein importer (PPI) family. |
PTM databases | |
| PhosphoSite | O43933. |
Proteomic databases | |
| PaxDb | O43933. |
| PRIDE | O43933. |
Protocols and materials databases | |
| DNASU | 5189. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000248633; ENSP00000248633; ENSG00000127980. ENST00000428214; ENSP00000394413; ENSG00000127980. |
| GeneID | 5189. |
| KEGG | hsa:5189. |
| UCSC | uc003uly.3. human. |
Organism-specific databases | |
| CTD | 5189. |
| GeneCards | GC07M092116. |
| HGNC | HGNC:8850. PEX1. |
| HPA | HPA020235. |
| MIM | 214100. phenotype. 601539. phenotype. 602136. gene. |
| neXtProt | NX_O43933. |
| Orphanet | 772. Infantile Refsum disease. 44. Neonatal adrenoleukodystrophy. 912. Zellweger syndrome. |
| PharmGKB | PA33192. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0464. |
| HOVERGEN | HBG008169. |
| InParanoid | O43933. |
| KO | K13338. |
| OMA | HSWEKEK. |
| PhylomeDB | O43933. |
Gene expression databases | |
| ArrayExpress | O43933. |
| Bgee | O43933. |
| CleanEx | HS_PEX1. |
| Genevestigator | O43933. |
| GermOnline | ENSG00000127980. Homo sapiens. |
Family and domain databases | |
| Gene3D | 2.40.40.20. 1 hit. |
| InterPro | IPR003593. AAA+_ATPase. IPR009010. Asp_de-COase-like_dom. IPR003959. ATPase_AAA_core. IPR003960. ATPase_AAA_CS. IPR015343. Peroxisome_synth_fac_1_a/b. IPR015342. PEX-1N. IPR025653. Pex1. [Graphical view] |
| PANTHER | PTHR23077:SF12. PTHR23077:SF12. 1 hit. |
| Pfam | PF00004. AAA. 2 hits. PF09262. PEX-1N. 1 hit. PF09263. PEX-2N. 1 hit. [Graphical view] |
| SMART | SM00382. AAA. 2 hits. [Graphical view] |
| SUPFAM | SSF50692. Asp_decarb_fold. 1 hit. |
| PROSITE | PS00674. AAA. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 5189. |
| NextBio | 20068. |
| SOURCE | Search... |
Entry information
| Entry name | PEX1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O43933 Secondary accession number(s): A4D1G3 Q99994 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
